We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+26.23%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$2.44B
AUM Growth
+$792M
Cap. Flow
+$442M
Cap. Flow %
18.15%
Top 10 Hldgs %
14.39%
Holding
5,222
New
2,059
Increased
1,821
Reduced
839
Closed
374

Sector Composition

Rank Sector Weight
1 Technology 12.14%
2 Healthcare 9.57%
3 Financials 8.79%
4 Industrials 7.76%
5 Consumer Discretionary 7.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KZR
3401
DELISTED
Kezar Life Sciences
KZR
$32K ﹤0.01%
+621
New +$31.3K
PACK icon
3402
Ranpak Holdings
PACK
$461M
$32K ﹤0.01%
+4,298
New +$31.6K
SMBC icon
3403
Southern Missouri Bancorp
SMBC
$848M
$32K ﹤0.01%
1,308
+1,195
+1,058% +$27.6K
STXS icon
3404
Stereotaxis
STXS
$145M
$32K ﹤0.01%
7,284
+4,286
+143% +$17.3K
UBS icon
3405
UBS Group
UBS
$176B
$32K ﹤0.01%
2,773
+830
+43% +$8.55K
PVLA
3406
Palvella Therapeutics
PVLA
$2.22B
$32K ﹤0.01%
+131
New +$30.6K
NBSE
3407
DELISTED
NeuBase Therapeutics, Inc. Common Stock
NBSE
$32K ﹤0.01%
+181
New +$30.3K
MBII
3408
DELISTED
Marrone Bio Innovations, Inc.
MBII
$32K ﹤0.01%
+27,321
New +$25.3K
AFI
3409
DELISTED
Armstrong Flooring, Inc.
AFI
$32K ﹤0.01%
10,856
+8,425
+347% +$21K
SBBP
3410
DELISTED
Strongbridge Biopharma plc.
SBBP
$32K ﹤0.01%
+8,561
New +$25.7K
BRT
3411
BRT Apartments
BRT
$266M
$31K ﹤0.01%
+2,881
New +$29.4K
CTXR icon
3412
Citius Pharmaceuticals
CTXR
$19.8M
$31K ﹤0.01%
+1,109
New +$24.3K
CVI icon
3413
CVR Energy
CVI
$3.42B
$31K ﹤0.01%
+1,562
New +$31.5K
CYCN icon
3414
Cyclerion Therapeutics
CYCN
$16.7M
$31K ﹤0.01%
259
+113
+77% +$9.45K
DGICA icon
3415
Donegal Group Class A
DGICA
$693M
$31K ﹤0.01%
+2,192
New +$31.3K
EWP icon
3416
iShares MSCI Spain ETF
EWP
$2.21B
$31K ﹤0.01%
1,395
+1,258
+918% +$26.7K
FBIZ icon
3417
First Business Financial Services
FBIZ
$597M
$31K ﹤0.01%
+1,857
New +$29K
FVCB icon
3418
FVCBankcorp
FVCB
$335M
$31K ﹤0.01%
+3,604
New +$31.6K
GNK icon
3419
Genco Shipping & Trading
GNK
$1.08B
$31K ﹤0.01%
4,930
+3,555
+259% +$20.6K
KVHI icon
3420
KVH Industries
KVHI
$151M
$31K ﹤0.01%
+3,480
New +$30.6K
LQDA icon
3421
Liquidia Corp
LQDA
$7.83B
$31K ﹤0.01%
3,677
+2,797
+318% +$21.2K
PHX
3422
DELISTED
PHX Minerals
PHX
$31K ﹤0.01%
11,708
+9,955
+568% +$37.2K
VERO
3423
DELISTED
Venus Concept
VERO
$31K ﹤0.01%
+54
New +$34.5K
PZN
3424
DELISTED
Pzena Investment Management, Inc. Class A
PZN
$31K ﹤0.01%
5,630
+3,244
+136% +$15.1K
TYME
3425
DELISTED
Tyme Technologies, Inc. Common Stock
TYME
$31K ﹤0.01%
23,107
+21,948
+1,894% +$29.9K

Similar funds

Tower Research Capital (TRC)'s Q2 2020 Portfolio in Review

As of Q2 2020, Tower Research Capital (TRC) held 5,222 positions worth $2.44B, up 48% from $1.64B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Tower Research Capital (TRC) deployed $442M of net new capital in Q2 2020, opening 2,059 new positions and adding to 1,821 existing holdings. Its largest new stake was Apple: 428,252 shares worth $39.1M.

By sector, the portfolio is most concentrated in Technology at 12% of assets, up from 3.1% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $342M trimmed.

  • Tower Research Capital (TRC)'s largest Q2 2020 buy was Apple: 428,252 shares worth $39.1M.
  • Tower Research Capital (TRC) added most to iPath Series B S&P 500 VIX Short-Term Futures ETN in Q2 2020, an estimated $55.3M increase.
  • Tower Research Capital (TRC)'s biggest Q2 2020 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $342M.
  • Tower Research Capital (TRC) fully exited First Trust Technology AlphaDEX Fund in Q2 2020, selling an estimated $2.52M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 14% of its $2.44B portfolio in Q2 2020.
  • Tower Research Capital (TRC) opened 2,059 new positions and closed 374 in Q2 2020.
  • Tower Research Capital (TRC)'s portfolio value rose 48% quarter-over-quarter to $2.44B.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2020, filed 13 Aug 2020.